» Articles » PMID: 15173613

Measurement of Protein-DNA Interactions in Vivo by Chromatin Immunoprecipitation

Overview
Specialty Molecular Biology
Date 2004 Jun 3
PMID 15173613
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Elucidating mechanisms controlling nuclear processes requires an understanding of the nucleoprotein structure of genes at endogenous chromosomal loci. Traditional approaches to measuring protein-DNA interactions in vitro have often failed to provide insights into physiological mechanisms. Given that most transcription factors interact with simple DNA sequence motifs, which are abundantly distributed throughout a genome, it is essential to pinpoint the small subset of sites bound by factors in vivo. Signaling mechanisms induce the assembly and modulation of complex patterns of histone acetylation, methylation, phosphorylation, and ubiquitination, which are crucial determinants of chromatin accessibility. These seemingly complex issues can be directly addressed by a powerful methodology termed the chromatin immunoprecipitation (ChIP) assay. ChIP analysis involves covalently trapping endogenous proteins at chromatin sites, thereby yielding snapshots of protein-DNA interactions and histone modifications within living cells. The chromatin is sonicated to generate small fragments, and an immunoprecipitation is conducted with an antibody against the desired factor or histone modification. Crosslinks are reversed, and polymerase chain reaction (PCR) is used to assess whether DNA sequences are recovered immune-specifically. Chromatin-domain scanning coupled with quantitative analysis is a powerful means of dissecting mechanisms by which signaling pathways target genes within a complex genome.

Citing Articles

Key epigenetic and signaling factors in the formation and maintenance of the blood-brain barrier.

Sadanandan J, Thomas S, Mathew I, Huang Z, Blackburn S, Tandon N Elife. 2024; 12.

PMID: 39670988 PMC: 11643625. DOI: 10.7554/eLife.86978.


The Cdk2-c-Myc-miR-571 Axis Regulates DNA Replication and Genomic Stability by Targeting Geminin.

Zhang Y, Li Z, Hao Q, Tan W, Sun J, Li J Cancer Res. 2019; 79(19):4896-4910.

PMID: 31431461 PMC: 7451049. DOI: 10.1158/0008-5472.CAN-19-0020.


GSH-C4 Acts as Anti-inflammatory Drug in Different Models of Canonical and Cell Autonomous Inflammation Through NFκB Inhibition.

Limongi D, Baldelli S, Checconi P, Marcocci M, De Chiara G, Fraternale A Front Immunol. 2019; 10:155.

PMID: 30787932 PMC: 6372722. DOI: 10.3389/fimmu.2019.00155.


Human leukemia mutations corrupt but do not abrogate GATA-2 function.

Katsumura K, Mehta C, Hewitt K, Soukup A, Fraga de Andrade I, Ranheim E Proc Natl Acad Sci U S A. 2018; 115(43):E10109-E10118.

PMID: 30301799 PMC: 6205465. DOI: 10.1073/pnas.1813015115.


GATA Factor-Regulated Samd14 Enhancer Confers Red Blood Cell Regeneration and Survival in Severe Anemia.

Hewitt K, Katsumura K, Matson D, Devadas P, Tanimura N, Hebert A Dev Cell. 2017; 42(3):213-225.e4.

PMID: 28787589 PMC: 5578808. DOI: 10.1016/j.devcel.2017.07.009.